TuHURA Biosciences (HURA) Assets Average (2011 - 2026)
TuHURA Biosciences' (HURA) quarterly Assets Average came in at $28.5 million in Q1 2026, up 64.88% year-on-year from $17.3 million in Q1 2025, and up 7.55% quarter-over-quarter from $26.5 million in Q4 2025.
TuHURA Biosciences (HURA) Assets Average (2011 - 2026) Analysis & Trends
TuHURA Biosciences' Assets Average history runs 16 years deep, the most recent figure standing at $28.5 million for Q1 2026.
- On a quarterly basis, Assets Average rose 64.88% year-over-year to $28.5 million in Q1 2026; TTM through Mar 2026 was $28.5 million, a 64.88% increase from a year earlier, with the FY2025 full-year figure at $23.7 million, up 80.83% from the prior year.
- Assets Average improved to $28.5 million in Q1 2026 per HURA's latest filing, from $26.5 million in the prior quarter.
- Across five years, Assets Average topped out at $30.2 million in Q3 2025 and bottomed at $2.7 million in Q3 2023.
- The 5-year median for Assets Average is $12.1 million (2024), against an average of $13.7 million.
- Across the five-year window, Assets Average plunged 81.29% in 2023 and surged 483.24% in 2025, its largest moves.
- Year by year, Assets Average stood at $11.6 million in 2022, then sank by 74.75% to $2.9 million in 2023, then surged by 312.87% to $12.1 million in 2024, then surged by 120.06% to $26.5 million in 2025, then advanced by 7.55% to $28.5 million in 2026.
- Per Business Quant, the three latest HURA Assets Average figures stand at $28.5 million (Q1 2026), $26.5 million (Q4 2025), and $30.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 65.01 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 40.89 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 8.37 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 2.30 Bn |
| 10 | TuHURA Biosciences | 132.62 Mn | 132.62 Mn | - | 28.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.53 Mn |
| Dec 31, 2025 | 26.53 Mn |
| Sep 30, 2025 | 30.16 Mn |
| Jun 30, 2025 | 24.63 Mn |
| Mar 31, 2025 | 17.30 Mn |
| Dec 31, 2024 | 12.05 Mn |
| Sep 30, 2024 | 5.17 Mn |
| Jun 30, 2024 | 6.82 Mn |
| Mar 31, 2024 | 5.90 Mn |
| Dec 31, 2023 | 2.92 Mn |
| Sep 30, 2023 | 2.73 Mn |
| Jun 30, 2023 | 5.36 Mn |
| Mar 31, 2023 | 8.33 Mn |
| Dec 31, 2022 | 11.56 Mn |
| Sep 30, 2022 | 14.58 Mn |
| Jun 30, 2022 | 14.37 Mn |
| Mar 31, 2022 | 15.26 Mn |
| Dec 31, 2021 | 20.03 Mn |
| Sep 30, 2021 | 17.94 Mn |
| Jun 30, 2021 | 16.20 Mn |